Rolf D. Kortmann

5.0k total citations · 2 hit papers
40 papers, 2.8k citations indexed

About

Rolf D. Kortmann is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Rolf D. Kortmann has authored 40 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Neurology. Recurrent topics in Rolf D. Kortmann's work include Glioma Diagnosis and Treatment (34 papers), Neuroblastoma Research and Treatments (11 papers) and Brain Metastases and Treatment (10 papers). Rolf D. Kortmann is often cited by papers focused on Glioma Diagnosis and Treatment (34 papers), Neuroblastoma Research and Treatments (11 papers) and Brain Metastases and Treatment (10 papers). Rolf D. Kortmann collaborates with scholars based in Germany, Switzerland and Austria. Rolf D. Kortmann's co-authors include Torsten Pietsch, Monika Warmuth‐Metz, Stefan Rutkowski, Joachim Kuehl, Frank Deinlein, Niels Soerensen, Angela Emser, Johannes Wolff, U. Bode and Holger Ottensmeier and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Rolf D. Kortmann

39 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

2009 571 citations Wolfgang Wick, Christian Hartmann et al. Journal of Clinical Oncology profile →
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

2005 505 citations Stefan Rutkowski, U. Bode et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolf D. Kortmann Germany	26	2.2k	1000	845	776	438	40	2.8k
Torsten Pietsch Germany	31	1.5k 0.7×	1.3k 1.3×	731 0.9×	819 1.1×	339 0.8×	78	3.4k
Tianni Zhou United States	26	1.8k 0.8×	835 0.8×	567 0.7×	983 1.3×	344 0.8×	34	2.4k
Regina I. Jakacki United States	35	2.3k 1.1×	969 1.0×	756 0.9×	1.8k 2.3×	608 1.4×	94	4.0k
Takamitsu Fujimaki Japan	30	1.4k 0.7×	682 0.7×	743 0.9×	917 1.2×	555 1.3×	112	3.2k
Anita Mahajan United States	32	1.9k 0.9×	590 0.6×	1.8k 2.1×	545 0.7×	511 1.2×	140	3.7k
Katja von Hoff Germany	26	1.4k 0.6×	1.1k 1.1×	394 0.5×	584 0.8×	246 0.6×	71	2.1k
Florence Laigle–Donadey France	30	2.1k 1.0×	836 0.8×	964 1.1×	408 0.5×	646 1.5×	74	3.1k
Joel Goldwein United States	17	1.5k 0.7×	638 0.6×	684 0.8×	670 0.9×	234 0.5×	33	2.2k
Astrid Gnekow Germany	29	1.9k 0.8×	640 0.6×	479 0.6×	1.5k 1.9×	582 1.3×	76	2.7k
Joel W. Goldwein United States	30	2.2k 1.0×	678 0.7×	987 1.2×	1.1k 1.5×	664 1.5×	66	3.3k

Countries citing papers authored by Rolf D. Kortmann

Since Specialization

Citations

This map shows the geographic impact of Rolf D. Kortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf D. Kortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf D. Kortmann more than expected).

Fields of papers citing papers by Rolf D. Kortmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf D. Kortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf D. Kortmann. The network helps show where Rolf D. Kortmann may publish in the future.

Co-authorship network of co-authors of Rolf D. Kortmann

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf D. Kortmann. A scholar is included among the top collaborators of Rolf D. Kortmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf D. Kortmann. Rolf D. Kortmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ottensmeier, Holger, Paul G. Schlegel, Matthias Eyrich, et al.. (2020). Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment. PLoS ONE. 15(1). e0227693–e0227693. 13 indexed citations

Calaminus, Gabriele, Didier Frappaz, Rolf D. Kortmann, et al.. (2017). Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial. Neuro-Oncology. 19(12). 1661–1672. 130 indexed citations

Sabel, Magnus, Gudrun Fleischhack, Stephan Tippelt, et al.. (2016). Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. Journal of Neuro-Oncology. 129(3). 515–524. 78 indexed citations

Bueren, André O. von, et al.. (2015). An Individual Patient Data Meta-Analysis on Characteristics, Treatments and Outcomes of Glioblastoma/ Gliosarcoma Patients with Metastases Outside of the Central Nervous System. PLoS ONE. 10(4). e0121592–e0121592. 48 indexed citations

Bueren, André O. von, Carsten Friedrich, Katja von Hoff, et al.. (2015). Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol. European Journal of Cancer. 51(16). 2434–2443. 26 indexed citations

Friedrich, Carsten, André O. von Bueren, Katja von Hoff, et al.. (2012). Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study. European Journal of Cancer. 49(4). 893–903. 66 indexed citations

Friedrich, Carsten, André O. von Bueren, Katja von Hoff, et al.. (2012). Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro-Oncology. 15(2). 224–234. 55 indexed citations

Hoff, Katja von, Bernward Hinkes, André O. von Bueren, et al.. (2011). Frequency, Risk‐Factors and Survival of Children With Atypical Teratoid Rhabdoid Tumors (AT/RT) of the CNS Diagnosed between 1988 and 2004, and Registered to the German HIT Database. Pediatric Blood & Cancer. 57(6). 978–985. 95 indexed citations

Bueren, André O. von, Christoph Oehler, Tarek Shalaby, et al.. (2011). c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer. 11(1). 74–74. 20 indexed citations

10.

Wick, Wolfgang, Christian Hartmann, Corinna Engel, et al.. (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology. 27(35). 5874–5880. 571 indexed citations breakdown →

11.

Roa, Wilson, James Z. Xing, Cormac Small, et al.. (2009). Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme. Expert Review of Anticancer Therapy. 9(11). 1643–1650. 10 indexed citations

12.

Brandes, Alba A., Enrico Franceschi, Alicia Tosoni, et al.. (2009). Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Critical Reviews in Oncology/Hematology. 71(2). 165–179. 41 indexed citations

13.

Wolff, Johannes, Pablo Hernáiz Driever, Bernhard Erdlenbruch, et al.. (2009). Intensive chemotherapy improves survival in pediatric high‐grade glioma after gross total resection: results of the HIT‐GBM‐C protocol. Cancer. 116(3). 705–712. 92 indexed citations

14.

Warmuth‐Metz, Monika, et al.. (2008). CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology. 50(5). 447–452. 57 indexed citations

15.

Bölling, Tobias, Andreas Schuck, H. Pape, et al.. (2008). Study protocol of the German "Registry for the Detection of Late Sequelae after Radiotherapy in Childhood and Adolescence" (RiSK). Radiation Oncology. 3(1). 10–10. 13 indexed citations

16.

Baumert, Brigitta G., Michael Brada, Jacques Bernier, et al.. (2008). EORTC 22972–26991/MRC BR10 trial: Fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Radiotherapy and Oncology. 88(2). 163–172. 14 indexed citations

17.

Coles, Charlotte E., Andrew Hoole, Susan Harden, et al.. (2003). Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. Radiotherapy and Oncology. 69(2). 189–194. 40 indexed citations

18.

Kortmann, Rolf D., et al.. (1999). Geometric accuracy of field alignment in fractionated stereotactic conformal radiotherapy of brain tumors. International Journal of Radiation Oncology*Biology*Physics. 43(4). 921–926. 47 indexed citations

19.

Claßen, Johannes, et al.. (1997). GliosarcomaCase Report and Review of the Literature. Acta Oncologica. 36(7). 771–774. 8 indexed citations

20.

Calaminus, Gabriele, et al.. (1997). Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT). Klinische Pädiatrie. 209(4). 222–227. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact